Evaluation of the Clinical, Neuropsychological and Psychosocial Situation of Patient With Eating Disorders.
1 other identifier
interventional
370
0 countries
N/A
Brief Summary
Eating disorders (ED) are serious mental illnesses with an excess mortality and many affects in the quality of life of patients and thier relatives. Management of ED is very difficult : the prognosis remains relatively poor both in terms of remission rate and quality of life. In this context, the contribution of new strategies for pathophysiological exploration and the development of therapeutic options are crucial. In this project the investigators aim to constitute un cohort of patients from a day unit specialized in the management of ED. A prospective follow-up will be offered to patients to assess their clinical and psycho-social evolution. The overall objective is to identify which factors are prognostic of clinical improvement of the ED. We also want to better characterize patients that will migrate from diagnosis to another.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2012
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 7, 2016
CompletedFirst Posted
Study publicly available on registry
July 12, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedJuly 12, 2016
July 1, 2016
2.7 years
July 7, 2016
July 7, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Frequency of remission rates
study of remission rates frequency at 12 months depending on the Brixton score assessed at baseline (assessment of cognitive flexibility). Remission is defined as disappearance of ED Diagnostic and Statistical Manual (DSM) criteria.
At the inclusion and at 12, 24 and 36 months
Secondary Outcomes (3)
score to another neuropsychological test (Iowa gambling task (IGT)
At the inclusion and at 12, 24 and 36 months
scores to another other neuropsychological test : Rey-Osterrieth complex figure
At the inclusion and at 12, 24 and 36 months
scores to another neuropsychological test : D2 test of attention
At the inclusion and at 12, 24 and 36 months
Study Arms (1)
Eating disorders
OTHERInterventions
Eligibility Criteria
You may qualify if:
- respond to DSM 4 criteria for ED
- Age 15 to 65 years
- Signing an informed consent.
- Affiliated to a social security scheme or being the beneficiary of such a scheme.
You may not qualify if:
- Manifest inability of the subject to understand / perform clinical and neuropsychological evaluations and tasks
- Major protected by law (guardianship)
- Privation of liberty by judicial or administrative decision
- Pregnant or lactating women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 7, 2016
First Posted
July 12, 2016
Study Start
February 1, 2012
Primary Completion
October 1, 2014
Study Completion
October 1, 2017
Last Updated
July 12, 2016
Record last verified: 2016-07
Data Sharing
- IPD Sharing
- Will not share